drugset / Trial / NCT03996486
Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia
SequentialOpen-labelOther
Summary
The purpose of this study is to investigate the safety of a test drug to treat hemophilia in adult men.
Timeline
- Start
- 2019-10-28
- Primary completion
- 2020-05-29
- Completion
- 2020-07-31
Outcome
Outcome not reported
Stopped: “Company decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BAY1093884 | Monoclonal antibody | 200 mg | Subcutaneous |